Researchers have discovered that a protein called cardiotrophin 1 (CT1) can trick the heart into growing in a healthy way and pumping more blood, just as it does in response to exercise and pregnancy. They show that this good kind of heart growth is very different from the harmful enlargement of the heart that occurs during heart failure. They also show that CT1 can repair heart damage and improve blood flow in animal models of heart failure.
The results are published in Cell Research. The research team is from The Ottawa Hospital, the University of Ottawa, the University of Ottawa Heart Institute and Carleton University.
Heart failure is a leading cause of death and disability in high-income countries and a growing problem around the world. It occurs when the heart can’t pump enough blood through the body, often because a heart attack has damaged the heart muscle tissue.
“When part of the heart dies, the remaining muscles try to adapt by getting bigger, but this happens in a dysfunctional way and it doesn’t actually help the heart pump more blood,” said Dr. Lynn Megeney, senior author of the study and a senior scientist at The Ottawa Hospital and professor at the University of Ottawa. “We found that CT1 causes heart muscles to grow in a more healthy way and it also stimulates blood vessel growth in the heart. This actually increases the heart’s ability to pump blood, just like what you would see with exercise and pregnancy.”
Dr. Megeney and his colleagues conducted a variety of studies in mice, rats and cells growing in the lab. In addition to CT-1, some of the studies involved a drug called phenylephrine (PE), which is known to cause the bad kind of heart growth. They found:
• Heart muscle cells treated with CT-1 become longer, healthier fibres, while those treated with PE just grow wider.
• CT-1 causes blood vessels to grow alongside the new heart muscle tissue and increases the heart’s ability to pump blood, while PE does neither.
• When CT-1 treatment stops, the heart goes back to its original condition, just like it does when exercise or pregnancy end. However, the dysfunctional heart growth caused by PE is irreversible.
• CT-1 dramatically improves heart function in two animal models of heart failure – one caused by a heart attack (affecting the left side of the heart) and one caused by high blood pressure in the lungs (pulmonary hypertension, affecting the right side of the heart).
• Both CT-1 and PE stimulate heart muscle growth through a molecular pathway that has traditionally been associated with promoting cell suicide (apoptosis), but CT-1 has a better ability to control this pathway.
“This experimental therapy is very exciting, particularly because it shows promise in treating both left and right heart failure,” said Dr. Duncan Stewart, a cardiologist, senior scientist and co-senior author on the paper who is also Executive Vice-President of Research at The Ottawa Hospital and a professor at the University of Ottawa. “Currently, the only treatment for right heart failure is a transplant. And although we have drugs that can reduce the symptoms of left heart failure, we can’t fix the problem, and left heart failure often leads to right heart failure over time.”
“An intriguing aspect of this research was how human CT1 was able to promote a healthy growth response in multiple animal models,” said co-author Dr. Patrick Burgon, scientist at the University of Ottawa Heart Institute and assistant professor at the University of Ottawa. “This suggests the action of CT1 is universally conserved and puts us much closer to therapy.”
The researchers also note that while exercise could theoretically have the same benefits as CT-1, people with heart failure are usually limited in their ability to exercise.
Dr. Megeney and Dr. Stewart have patents pending for the use of CT-1 to treat heart conditions and they hope to develop partnerships to test this protein in patients. If this testing is successful it will take a number of years for the treatment to become widely available.
The Latest on: Heart failure
- Study: Stay in School to Skip Heart Diseaseon June 25, 2019 at 11:40 am
State laws mandating education for U.S. children took root well over a century ago to protect child welfare. A new study suggests such policies improved American health as well. About a third of those ... […]
- More years of childhood education may reduce adult heart disease riskon June 25, 2019 at 11:04 am
State policies requiring children to attend additional years of school may result in a reduced risk for heart disease and improvements in several cardiovascular risk factors in adulthood ... […]
- Spending more time in school could reduce heart disease, study suggestson June 25, 2019 at 10:25 am
New research offers a compelling case for staying in school: American adults who spent more time in the classroom as kids have a lower risk of heart disease. "As a society, we should be thinking about ... […]
- Assessing Heart Failure in Long-Term Care Facilitieson June 25, 2019 at 9:06 am
Evidence suggests the most crucial elements to successful heart failure (HF) management in long-term care (LTC) include improving staffs' HF knowledge to recognize and intervene in early symptom ... […]
- Scientists investigate genomic pillars behind transition from healthy hearts to heart failureon June 25, 2019 at 2:10 am
Scientists investigating heart failure have been limited to studying diseased heart tissue in the lab -- understandably, as people don't tend to pluck out a healthy heart for the sake of research. But ... […]
- Long Island pizzeria owner, who was latest American to die in Dominican Republic, died of heart failureon June 24, 2019 at 11:22 pm
A Long Island pizzeria owner, who recently became the latest American to die in the Dominican Republic, died from respiratory and heart failure following a long history of health problems, according ... […]
- Most recent American death in Dominican Republic due to heart failure, attorney general's office sayson June 24, 2019 at 7:42 pm
(CNN)Vittorio Caruso, the most recent American to die in the Dominican Republic, died from respiratory and heart failure after a long history of related-health problems, the country's Attorney General ... […]
- Mesoblast Trades Higher After Heart Failure Cell Therapy Receives Orphan Drug Statuson June 24, 2019 at 2:37 pm
Mesoblast Limited (NASDAQ: MESO) product rexlemestrocel-L has received Orphan Drug Destination from the U.S. Food and Drug Administration for prevention of gastrointestinal bleeding in patients ... […]
- The More Holidays You Take, the Less Chance You Have of Developing Heart Diseaseon June 24, 2019 at 7:38 am
You don't need to be a brain surgeon to know that taking a break from work once in a while is good for the mind. But if new research is to be believed, taking a holiday could have a demonstrable ... […]
- Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failureon June 24, 2019 at 2:13 am
Heart failure (HF) is a life-threatening syndrome characterized by an inability of the heart to meet the metabolic demands of the body. HF costs the US more than $34 billion a year to treat 6 million ... […]
via Google News and Bing News